We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+12.89%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$4.44B
AUM Growth
-$122M
Cap. Flow
-$598M
Cap. Flow %
-13.48%
Top 10 Hldgs %
66%
Holding
61
New
7
Increased
11
Reduced
20
Closed
12

Top Buys

Rank Stock Value
1
UHS icon
Universal Health Services
UHS
+$76.5M
2
CI icon
Cigna
CI
+$56M
3
CLVT icon
Clarivate
CLVT
+$48.2M
4
CTVA icon
Corteva
CTVA
+$26.5M
5
WBD icon
Warner Bros
WBD
+$21.1M

Sector Composition

Rank Sector Weight
1 Healthcare 40.66%
2 Technology 19.2%
3 Materials 7.49%
4 Industrials 6.59%
5 Consumer Discretionary 5.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVLV icon
26
Evolv Technologies
EVLV
$1.05B
$29M 0.65%
4,829,195
-1,487,679
-24% -$7.03M
CAH icon
27
Cardinal Health
CAH
$54.9B
$24.3M 0.55%
257,330
+116,298
+82% +$9.82M
FDX icon
28
FedEx
FDX
$74B
$23.7M 0.53%
95,628
-66,955
-41% -$15.3M
HPE icon
29
Hewlett Packard
HPE
$67.5B
$21M 0.47%
+1,250,000
New +$19.1M
WBD icon
30
Warner Bros
WBD
$65.4B
$20.4M 0.46%
+1,624,300
New +$21.1M
MTCH icon
31
Match Group
MTCH
$9.6B
$19.9M 0.45%
474,886
BFLY icon
32
Butterfly Network
BFLY
$2.24B
$18.5M 0.42%
8,033,501
FLEX icon
33
Flex
FLEX
$46.4B
$17.2M 0.39%
825,207
-1,725,751
-68% -$30.8M
BHC icon
34
Bausch Health
BHC
$2.54B
$14.1M 0.32%
+1,766,395
New +$13M
AMZN icon
35
Amazon
AMZN
$2.99T
$13M 0.29%
100,017
-354,701
-78% -$40.5M
DMRC icon
36
Digimarc Corp
DMRC
$168M
$12.8M 0.29%
434,497
UNP icon
37
Union Pacific
UNP
$175B
$12.8M 0.29%
62,504
CCEP icon
38
Coca-Cola Europacific Partners
CCEP
$45.9B
$12.1M 0.27%
187,810
-1,015,122
-84% -$64.5M
CHTR icon
39
Charter Communications
CHTR
$17.5B
$11.5M 0.26%
+31,366
New +$10.7M
KNX icon
40
Knight Transportation
KNX
$11.5B
$5.56M 0.13%
100,000
-276,450
-73% -$15.4M
QSI icon
41
Quantum-Si Incorporated
QSI
$170M
$4.32M 0.1%
2,415,990
-1,800,000
-43% -$2.82M
CANO
42
DELISTED
Cano Health, Inc.
CANO
$2.36M 0.05%
17,001
+7,500
+79% +$962K
CELL
43
DELISTED
PhenomeX Inc. Common Stock
CELL
$1.87M 0.04%
3,816,313
DNB
44
DELISTED
Dun & Bradstreet
DNB
$1.79M 0.04%
154,374
RPID icon
45
Rapid Micro Biosystems
RPID
$104M
$1.32M 0.03%
1,318,288
+500,000
+61% +$506K
CBUS icon
46
Cibus
CBUS
$144M
$1.26M 0.03%
+119,963
New +$2.16M
BFLY.WS
47
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$403K 0.01%
1,713,333
DOMA
48
DELISTED
Doma Holdings, Inc.
DOMA
$98.8K ﹤0.01%
19,994
-6
-0% -$48
AVTR icon
49
Avantor
AVTR
$9.08B
-1,862,800
Closed -$39.4M
BABA icon
50
Alibaba
BABA
$309B
-403,063
Closed -$41.2M

Similar funds

Glenview Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Glenview Capital Management held 61 positions worth $4.44B, down 2.7% from $4.56B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Glenview Capital Management withdrew a net $598M in Q2 2023, closing 12 positions and reducing 20 holdings. Its most notable exit was Lennox International, an estimated $59.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 37% a quarter earlier, followed by Technology and Materials.

Against the trend, Glenview Capital Management opened a new position in Warner Bros worth $20.4M.

  • Glenview Capital Management's largest Q2 2023 buy was Warner Bros: 1,624,300 shares worth $20.4M.
  • Glenview Capital Management added most to Universal Health Services in Q2 2023, an estimated $76.5M increase.
  • Glenview Capital Management's biggest Q2 2023 reduction was Fiserv Inc, cutting an estimated $149M.
  • Glenview Capital Management fully exited Lennox International in Q2 2023, selling an estimated $59.8M.
  • Glenview Capital Management's ten largest holdings make up 66% of its $4.44B portfolio in Q2 2023.
  • Glenview Capital Management opened 7 new positions and closed 12 in Q2 2023.
  • Glenview Capital Management's portfolio value fell 2.7% quarter-over-quarter to $4.44B.

Based on Glenview Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.